Delay nearsightedness in high-risk children with nightly low-dose eye drops
Official title: Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial
Run by Ohio State University · NCT07567040 · Data updated 2026-11-12
This will test whether giving children ages 6–11 nightly 0.05% atropine eye drops delays the start of nearsightedness compared with nightly placebo drops.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 6 Years to 11 Years |
| Sex | All |
| Enrollment | 664 (estimated) |
| Sponsor | Ohio State University Academic / other |
| Locations | 13 sites (Birmingham, Alabama and 12 other locations) |
| Status | Recruiting |
| Started | May 27, 2026 |
| Main results expected | May 15, 2028 |
| Study ends | May 15, 2028 |
| Registry record updated | September 21, 2026 |
| Trial ID | NCT07567040 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 6–11 judged to be at high risk for myopia onset who meet the study's refractive and ocular health criteria and can adhere to nightly drops and regular visits.
✕Probably not a fit
Children who already have at least −0.75 D myopia in either eye, who have strabismus, a known allergy to atropine, systemic issues affecting accommodation, or who cannot commit to nightly dosing and follow-up are unlikely to benefit from this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The DONUT trial is a multicenter, randomized, placebo-controlled Phase 3 trial enrolling 606 children aged 6–11 who are at high risk for developing myopia. Participants are randomized to nightly 0.05% atropine eye drops or matching placebo and are followed every six months for at least two years to measure refractive error and axial length. The primary outcome is the two-year cumulative incidence of myopia; a key secondary outcome is the rate of axial elongation. A short run-in period with unit-dose artificial tears confirms participants can reliably administer nightly drops before randomization.
Why it matters
Potential benefit: If successful, nightly low‑dose atropine could reduce how many children develop myopia and slow the eye growth that leads to worsening vision.
How similar studies have gone: Previous trials have shown low‑dose atropine can slow myopia progression, but using 0.05% atropine specifically to delay the initial onset of myopia is less well tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Refractive Error (cycloplegic autorefraction, spherical equivalent, at least one eye, inclusive) 6 years: -0.74 D to +0.75 D 7 and 8 years: -0.74 D to +0.50 D 9 and 10 years: -0.74 D to +0.25 D 11 years: -0.74 D to plano * Neither eye has -0.75 D or more myopia, spherical component * Anisometropia: Less than 1.50 D difference between OD and OS, cycloplegic autorefraction, spherical equivalent * Astigmatism: Less than 1.50 DC in both eyes by cycloplegic autorefraction * Successfully complete run-in period: take at least 90% of unit dose artificial tears for 2 to 4 weeks (# of unit-dose vials used divided by # nights since baseline visit must equal 0.90 or greater) Exclusion Criteria: * If Visit 2 (randomization visit) is not completed within 4 weeks of the baseline, eligibility visit. * Presence of strabismus (intermittent or constant) based on unilateral cover test at distance and near * Known allergy to atropine * Systemic issues that may affect accommodation or convergence (e.g., multiple sclerosis, myasthenia gravis, Graves ophthalmopathy, diabetes mellitus, Parkinson's disease, Down syndrome, etc.) * Ocular disease (e.g., congenital glaucoma, retinal disease, nystagmus, amblyopia, etc.) * Ocular surgery (e.g., cataracts, strabismus) * Any previous myopia prevention/control therapy (e.g., atropine, soft contact lenses, orthokeratology, myopia control spectacles, etc.) for more than one month * Pregnancy by self-report
Where it's running
-
University of Alabama School of Optometry
Birmingham, Alabama, United States Recruiting -
University of California, Berkeley, School of Optometry
Berkeley, California, United States Recruiting -
Southern California College of Optometry at Marshall B. Ketchum University
Fullerton, California, United States Recruiting -
Stanford University
Palo Alto, California, United States Recruiting -
Illinois College of Optometry
Chicago, Illinois, United States Recruiting -
Indiana University
Bloomington, Indiana, United States Recruiting
Show 7 more locations
-
New England College of Optometry
Boston, Massachusetts, United States Recruiting -
State University of New York College of Optometry
New York, New York, United States Recruiting -
The Ohio State University College of Optometry
Columbus, Ohio, United States Recruiting -
Pennsylvania College of Optometry at Drexel University
Elkins Park, Pennsylvania, United States Recruiting -
Southern College of Optometry
Memphis, Tennessee, United States Recruiting -
University of Houston College of Optometry
Houston, Texas, United States Recruiting -
Case Western Reserve Department of Ophthalmology
Cleveland, Ohio, United States Not yet recruiting
Study contacts
- Study coordinator: Lisa A Jordan, PhD
- Email: jordan.646@osu.edu
- Phone: 614-247-7321
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating a device for screening vision problems in young children
This study is testing a new device to see if it can effectively find vision problems in children aged 3 to 8, whether they wear glasses or not.
-
Optimizing light exposure to prevent and control myopia in children
This study tests if changing classroom lighting to mimic sunlight or using a smartphone app to guide light exposure can help prevent and control myopia in primary school children.
-
Hyperopic reserve screening for kindergartners in Beijing
A population-wide screening tests whether senior kindergarten children in Beijing have enough hyperopic reserve to help prevent future myopia.
-
Do dual-focus multifocal contact lenses improve hand-eye coordination and sports vision compared with your usual lenses
This study tests whether wearing dual-focus multifocal contact lenses improves hand-eye coordination and sports vision in adults who play baseball or softball and normally wear contact lenses.
-
Two monthly silicone hydrogel multifocal toric contact lenses in wearers with astigmatism and myopia
This study tests whether two popular soft multifocal toric contact lenses perform differently in adults who need vision correction for astigmatism and myopia.
-
Seeing clearly in low light after Ray-Tracing guided LASIK
A trial tests how well WaveLight Plus LASIK works for people with myopia and astigmatism and whether patients are satisfied after the procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.